Biochemical Cardiovascular Risk Factors After Hypertensive Pregnancy Disorders: A Systematic Review and Meta-analysis
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The objective of this study was to perform a systematic review and meta-analysis of studies assessing biochemical cardiovascular risk factors in women with previous hypertensive pregnancy disorders and women with previous normotensive pregnancies. Data were collected from PubMed and EMBASE (from inception to February 28, 2011) supplemented by manual searches of bibliographies. Included were cohort studies and case-control studies assessing biochemical cardiovascular risk factors in women with previous hypertensive pregnancy disorders compared with women with previous normotensive pregnancies. Of 2573 studies reviewed for eligibility, quality, and data extraction, 22 were included in the review, of which 15 could be meta-analyzed. The pooled mean differences for the outcomes of interest were 0.17 mmol/L (95% confidence interval [CI], 0.08-0.25 mmol/L) for glucose (10 studies), 3.46 mU/mL (95% CI, 2.34-4.58 mU/mL) for insulin (5 studies), 0.13 mmol/L (95% CI, 0.05-0.21) for triglycerides (10 studies), 0.22 mmol/L (95% CI, 0.11-0.33 mmol/L) for total cholesterol (11 studies), -0.11 mmol/L (95% CI, -0.18 to -0.04 mmol/L) for high-density lipoprotein cholesterol (10 studies), and 0.21 mmol/L (95% CI, 0.10-0.32) for low-density lipoprotein cholesterol (9 studies), all in the disadvantage in women with previous hypertensive pregnancy disorders. Analyses for preeclampsia alone showed similar results. CONTINUED LEARNING OBJECTIVES: After completing this CME activity, physicians should be better able to assess the long-term cardiovascular consequences after hypertensive pregnancy disorders, evaluate and interpret the evidence regarding biochemical cardiovascular risk factor assessment after pregnancy, and counsel women with a history of hypertensive pregnancy disorders as to the effectiveness of cardiovascular risk factor assessment in the primary prevention of cardiovascular disease. CONCLUSIONS: Women with previous hypertensive pregnancy disorders have higher glucose, insulin, triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol levels measured after pregnancy compared with women with previous normotensive pregnancies. These biochemical cardiovascular risk factors may identify women who will benefit from primary prevention of cardiovascular disease. TARGET AUDIENCE: Obstetricians and gynecologists, family physicians.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440 · cited 1×
“The risk of an adverse cardiovascular event increases progressively with increasing absolute levels of microalbuminuria.(45) Low-grade albuminuria carries a 3-fold increased risk of cardiovascular disease (in women with the sex-specific median of Q7.”
BackgroundIrgens, H. U., Roberts, J. M., Reisæter, L., Irgens, L. M., & Lie, R. T. (2001) · BMJ · doi:10.1136/bmj.323.7323.1213 · Cited by 1,040 · cited 1×
“Hypertensive Pregnancy Disorders and the Association With Cardiovascular Disease, Implications and Future Research Women with preeclampsia have a 2-fold higher risk of death from cardiovascular disease later in life and even a higher risk in combination with certain circumstances, that is, preterm delivery, intrauteri…”
BackgroundCardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses
McDonald, S. D., Malinowski, A., Zhou, Q., Yusuf, S., & Devereaux, P. J. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.06.042 · Cited by 924 · cited 1×
“It has been suggested that pregnancy acts as a natural stress test that can predict women’s health in later life.(4) Pregnancy can unmask subclinical diseases including hypertensive disorders that express in later life by the effects of aging clinically diagnosed as cardiovascular disease.”
BackgroundWilson, B. J., Watson, M. S., Prescott, G. J., Sunderland, S., Campbell, D. M., Hannaford, P., & Smith, W. C. S. (2003) · BMJ · doi:10.1136/bmj.326.7394.845 · Cited by 723
Risk factors for pre‐eclampsia in nulliparous and parous women: the Jerusalem Perinatal Study
Funai, E. F., Paltiel, O. B., Malaspina, D., Friedlander, Y., Deutsch, L., & Harlap, S. (2005) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.2004.00623.x · Cited by 135 · cited 1×
“Hypertensive Pregnancy Disorders and the Association With Cardiovascular Disease, Implications and Future Research Women with preeclampsia have a 2-fold higher risk of death from cardiovascular disease later in life and even a higher risk in combination with certain circumstances, that is, preterm delivery, intrauteri…”
BackgroundWomen's hearts need special treatment
Burell, G., & Granlund, B. (2002) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm0903_05 · Cited by 103 · cited 1×
“Cardiovascular disease is the leading cause of death in women in the Western world.(5) Both hypertensive disorders in pregnancy and cardiovascular disease share features of subclinical vascular (endothelium) damage clinically manifesting as metabolic syndrome and arteriosclerosis.”
Background
Cited by
Parikh, N. I., Gonzalez, J. M., Anderson, C. A. M., Judd, S. E., Rexrode, K. M., Hlatky, M. A., Gunderson, E. P., Stuart, J. J., Vaidya, D., & On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, T. A. V. B. C. O. C. A. S. N. A. T. S. C. (2021) · Circulation · doi:10.1161/cir.0000000000000961 · Cited by 743
Okoth, K., Chandan, J. S., Marshall, T., Thangaratinam, S., Thomas, G. N., Nirantharakumar, K., & Adderley, N. J. (2020) · BMJ · doi:10.1136/bmj.m3502 · Cited by 416
Sex differences in cardiovascular disease – Impact on care and outcomes
Humphries, K. H., Izadnegahdar, M., Sedlak, T., Saw, J., Johnston, N., Schenck-Gustafsson, K., Shah, R. U., Regitz-Zagrosek, V., Grewal, J., Vaccarino, V., et al. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.04.001 · Cited by 273
Pre‐eclampsia and long‐term health outcomes for mother and infant: an umbrella review
Pittara, T., Vyrides, A., Lamnisos, D., & Giannakou, K. (2021) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16683 · Cited by 125
Metadata
- Authors
- Hermes, W., Ket, J. C. F., van Pampus, M. G., Franx, A., Veenendaal, M. V. E., Kolster, C., Tamsma, J. T., Bloemenkamp, K. W. M., Ponjee, G., van der Hout, E., ten Horn, H., Loix, S., Mol, B. W., & de Groot, C. J. M.
- Venue
- Obstetrical & Gynecological Survey
- Published
- 2012-12
- Volume
- 67
- Issue
- 12
- Pages
- 792-808
- ISSN
- 0029-7828 (ISSN-L)
- OpenAlex
- W2002490172
- Cited by
- 57
- References
- 6
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biochemical Cardiovascular Risk Factors After Hypertensive Pregnancy Disorders: A Systematic Review and Meta-analysis. https://app.cochat.ai/papers/10.1097/ogx.0b013e31827682fc
- The paper
- Hermes, W., Ket, J. C. F., van Pampus, M. G., Franx, A., Veenendaal, M. V. E., Kolster, C., Tamsma, J. T., Bloemenkamp, K. W. M., Ponjee, G., van der Hout, E., ten Horn, H., Loix, S., Mol, B. W., & de Groot, C. J. M. (2012). Biochemical Cardiovascular Risk Factors After Hypertensive Pregnancy Disorders: A Systematic Review and Meta-analysis. Obstetrical & Gynecological Survey. https://doi.org/10.1097/ogx.0b013e31827682fc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.